Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study
Eur Respir J
.
2017 Mar 22;49(3):1601546.
doi: 10.1183/13993003.01546-2016.
Print 2017 Mar.
Authors
David Z Roth
1
2
,
Lisa A Ronald
2
3
,
Daphne Ling
4
,
Leslie Y Chiang
2
,
Victoria J Cook
2
3
,
Muhammad G Morshed
5
6
,
James C Johnston
7
3
Affiliations
1
School of Public and Population Health, University of British Columbia, Vancouver, BC, Canada.
2
BC Centre for Disease Control, Vancouver, BC, Canada.
3
Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada.
4
Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada.
5
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
6
BC Centre for Disease Control Public Health Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
7
BC Centre for Disease Control, Vancouver, BC, Canada
[email protected]
.
PMID:
28331032
DOI:
10.1183/13993003.01546-2016
No abstract available
Publication types
Letter
MeSH terms
British Columbia / epidemiology
Humans
Interferon-gamma Release Tests / methods*
Latent Tuberculosis / diagnosis*
Latent Tuberculosis / drug therapy
Latent Tuberculosis / epidemiology
Mass Screening
Tuberculin Test